Literature DB >> 6478457

Phase II study of spirogermanium in the treatment of metastatic breast cancer.

K Pinnamaneni, H Y Yap, S S Legha, G R Blumenschein, G P Bodey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478457

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  2 in total

Review 1.  Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide.

Authors:  A G Schauss
Journal:  Biol Trace Elem Res       Date:  1991-06       Impact factor: 3.738

Review 2.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.